| Family Medical Specialties | |
|
516 W 14th Ave Ste 100 Holdrege NE 68949-1215 | |
| (308) 995-4431 | |
| (308) 995-3247 |
| Full Name | Family Medical Specialties |
|---|---|
| Speciality | Internal Medicine |
| Location | 516 W 14th Ave, Holdrege, Nebraska |
| Authorized Official Name and Position | William Max Sandy (CEO) |
| Authorized Official Contact | 3089954431 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Medical Specialties 516 W 14th Ave Ste 100 Holdrege NE 68949-1216 Ph: (308) 995-4431 | Family Medical Specialties 516 W 14th Ave Ste 100 Holdrege NE 68949-1215 Ph: (308) 995-4431 |
| NPI Number | 1427089010 |
|---|---|
| Provider Enumeration Date | 07/05/2006 |
| Last Update Date | 06/23/2008 |
| Medicare PECOS PAC ID | 2769372002 |
|---|---|
| Medicare Enrollment ID | O20040318001427 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427089010 | NPI | - | NPPES |
| 47063910813 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Charlotte A Wirges |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528004231 PECOS PAC ID: 5092893289 Enrollment ID: I20091230000011 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Scott M Ehresman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1972548477 PECOS PAC ID: 4284774050 Enrollment ID: I20091230000016 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Jeffrey R Berney |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1467498170 PECOS PAC ID: 8729166913 Enrollment ID: I20100116000387 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Thomas B Smith |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1902842610 PECOS PAC ID: 0648358838 Enrollment ID: I20100116000396 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | William M Sandy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841236692 PECOS PAC ID: 7911085105 Enrollment ID: I20100116000411 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Mileah Panter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841568722 PECOS PAC ID: 1557526399 Enrollment ID: I20120629000329 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Shane M Smith |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1184705980 PECOS PAC ID: 5698841955 Enrollment ID: I20131009002190 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Benjamin Z Egger |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1881076347 PECOS PAC ID: 1759686256 Enrollment ID: I20180507000607 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Jacob C Peterson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1679954028 PECOS PAC ID: 5294040275 Enrollment ID: I20180507000732 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Kathryn C Thelen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1104209337 PECOS PAC ID: 9638474976 Enrollment ID: I20180507000739 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Krista M Stoecker |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1487032181 PECOS PAC ID: 2860708849 Enrollment ID: I20180703001777 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Adam Tyler Haussler |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417290560 PECOS PAC ID: 7517195043 Enrollment ID: I20200609002798 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
| Provider Name | Danika M Peterson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1760902159 PECOS PAC ID: 9537433958 Enrollment ID: I20200903001319 |
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
News Archive
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
Children's genetic risks for obesity may be reduced by interventions that strengthen family communication and help children manage their emotions and feelings of satiety, according to a new review of research on the problem.
The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).
According to leading researchers there is more evidence than ever before that fiber-rich foods prevent bowel cancer. They analyzed the most up-to-date research on the disease and said there is now "convincing" evidence that foods containing fiber can offer protection. An earlier 2007 concluded that dietary fiber "probably" cuts the risk of the disease but this new analysis is stronger they say. New evidence includes research that says three servings a day of cereal fiber and whole grains reduce the risk.
Sosei Group Corporation, the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., has initiated a Phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis.
› Verified 9 days ago
Bilka Chiropractic, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 701 4th Ave. Ste. 3, Holdrege, NE 68946 Phone: 308-995-2355 Fax: 308-995-2355 | |
Phelps Memorial Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1315 Tibbals St, Holdrege, NE 68949 Phone: 308-995-6111 | |
Holdrege Medical Clinic, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 516 W 14th Ave Ste 100, Holdrege, NE 68949 Phone: 308-995-4431 | |
High Plains Clinic, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1315 Tibbals St, Holdrege, NE 68949 Phone: 308-995-6111 Fax: 308-995-4868 | |
Two Rivers Public Health Department Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 701 4th Ave, Suite 1, Holdrege, NE 68949 Phone: 308-995-4778 Fax: 308-995-4073 | |
Phelps Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1315 Tibbals St, Holdrege, NE 68949 Phone: 308-995-6111 |